Alliance Pharma PLC
LSE:APH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Alliance Pharma PLC
LSE:APH
|
UK |
|
Immunome Inc
NASDAQ:IMNM
|
US |
|
Premium Resources Ltd
XTSX:PREM
|
CA |
|
Samyung Trading Co Ltd
KRX:002810
|
KR |
|
Envirosuite Ltd
ASX:EVS
|
AU |
|
LFTD Partners Inc
OTC:LIFD
|
US |
|
Y
|
Yandex NV
F:YDX
|
NL |
|
Cordlife Group Ltd
SGX:P8A
|
SG |
|
System1 Group PLC
LSE:SYS1
|
UK |
|
Capelli SA
PAR:ALCAP
|
FR |
|
Rezolve AI PLC
F:O5F
|
UK |
|
Datametrex AI Ltd
XTSX:DM
|
CA |
|
Stericycle Inc
NASDAQ:SRCL
|
US |
|
Heartland Financial USA Inc
NASDAQ:HTLF
|
US |
|
S
|
StubHub Holdings Inc
NYSE:STUB
|
US |
|
Wowow Inc
TSE:4839
|
JP |
|
I
|
Investeko SA
WSE:IVE
|
PL |
|
Victoria Care Indonesia Tbk PT
IDX:VICI
|
ID |
|
Cardno Ltd
ASX:CDD
|
AU |
|
W
|
Wise iTech Co Ltd
KOSDAQ:065370
|
KR |
|
Colliers International Group Inc
TSX:CIGI
|
CA |
|
C
|
Charlie's Holdings Inc
OTC:CHUC
|
US |
|
B
|
Bendigo and Adelaide Bank Ltd
OTC:BXRBF
|
AU |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is APH's stock price target?
Not Available
APH doesn't have any price targets made by Wall Street professionals.
What is Alliance Pharma PLC's Revenue forecast?
Projected CAGR
9%
For the last 14 years the compound annual growth rate for Alliance Pharma PLC's revenue is 10%. The projected CAGR for the next 3 years is 9%.
What is Alliance Pharma PLC's Operating Income forecast?
Projected CAGR
16%
For the last 14 years the compound annual growth rate for Alliance Pharma PLC's operating income is 4%. The projected CAGR for the next 3 years is 16%.